Pet-yksikkö

Julkaisut 2007
Publications 2007

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Bax JJ et al. Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts?
2 Bäcklund T et al. Activation of protective and damaging components of the cardiac renin-angiotensin system after myocardial infarction in experimental diabetes.
3 de Leon MJ et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.
4 Grönholm P et al. Neural correlates of naming newly learned objects in MCI.
5 Grönroos T. [18F]-fluoroerythronitroimidazole, tumour hypoxia and positron emission tomography.
6 Grönroos T, Minn H. Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology.
7 Guiducci L et al. Biodistribution of the fatty acid analogue 18F-FTHA: Plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia.
8 Haltia LT et al. Effects of intravenous glucose on dopaminergic function in the human brain in vivo.
9 Haltia LT et al. Brain white matter expansion in human obesity and the recovering effect of dieting.
10 Hannukainen JC et al. Myocardial and peripheral vascular functional adaptation to exersice training.
11 Hannukainen JC et al. Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins.
12 Havu-Aurén K et al. Uptake of 4-borono-2-(18F)fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
13 Heinonen I et al. Role of adenosine in regulating the heterogeneity of skeletal muscle blood flow during exercise in humans.
14 Hietala J, Syvälahti E. Psykoosien hoitoon tarkoitetut lääkeaineet.
15 Hirvonen J et al. Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and (carbonyl-11C)WAY-100635 - considerations on the validity of cerebellum as a reference region.
16 Ibe W et al. Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment.
17 Ilveskoski E et al. Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype.
18 Ingman K. Pharmacological Modulation of the Alcohol Drinking of AA rats, an Animal Model of High-alcohol Drinking.
19 Innis RB et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
20 Iozzo P et al. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.
21 Julkunen L. Rehabilitation of Somatosensory and Visual Field Deficits after Stroke. A Clinical, Neurophysiological and Functional Imaging Study.
22 Juslin A. Alignment of Cardiac Structures in (15O)H2O Perfusion PET Studies.
23 Juslin A et al. Alignment of 3-dimensional cardiac structures in O-15-labeled water PET emission images with mutual information.
24 Kalliokoski KK et al. Contraction-induced (18F)-fluoro-deoxy-glucose uptake can be measured in human calf muscle using high-resolution PET.
25 Kankaanranta L et al. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
26 Kauhanen S et al. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
27 Kemppainen NM et al. Pet amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment .
28 Kiviniemi TO et al. A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve.
29 Kiviniemi TO et al. Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography.
30 Knaapen P et al. Myocardial energetics and efficiency: Current status of the noninvasive approach.
31 Knaapen P et al. The failing heart.
32 Knuuti J. PET Imaging of heart and skeletal muscle: An overview.
33 Knuuti J et al. Sydämen tietokonetomografia.
34 Knuuti J et al. Effect of estradiol-drospirenone hormone treatment on myocardial perfusion reserve in postmenopausal women with angina pectoris.
35 Knuuti J, Lauerma K. Imaging of the failing heart.
36 Koikkalainen J et al. Shape variability of the human striatum - effects of age and gender.
37 Korja M et al. Hyperostosis frontalis interna as a novel finding in Unverricht-Lundborg disease.
38 Korja M et al. Substantial thalamostriatal dopaminergic defect in Unverricht-Lundborg disase.
39 Koskenvuo JW et al. Cardiac MRI: accuracy of simultaneous measurement of left and right ventricular parameters using three different sequences.
40 Koskivuo IO et al. Whole body positron emission tomography in follow-up of high risk melanoma.
41 Kytö V et al. Incidence of fatal myocarditis: A population-based study in Finland.
42 Kähönen M et al. Angiotensin-converting enzyme gene polymorphism and coronary reactivity in young men.
43 Laaksonen MS et al. Myocardial perfusion during exercise in endurance-trained and untrained humans.
44 Laitio R. The Effects of Xenon Anesthesia on the Brain. Positron Emission Tomography and EEG Studies on Healthy Subjects.
45 Laitio RM et al. Effects of xenon anesthesia on cerebral blood flow in humans: a positron emission tomography study .
46 Laitio T et al., inventor. Method and arrangement for predicting perioperative myocardial ischemia.
47 Laitio T et al. The role of heart rate variability in risk stratification for adverse postoperative cardiac events.
48 Lautamäki R et al. Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease.
49 Lautamäki R et al. Cardiac sympathetic neuronal imaging using PET.
50 Liukko KE et al. Non-invasive estimation of subcutaneous and visceral adipose tissue blood flow by using (15O)H2O PET with image derived input functions.
51 Lumme V et al. Dopamine D2/D3 receptor binding in the anterior cingulate cortex and executive functioning.
52 Luomala M et al. High plasma levels of CD40 are associated with low coenzyme Q and vitamin E content of low-density lipoprotein in healthy men.
53 Lyoo CH et al. Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on Parkinsonian motor deficits and freezing of gait.
54 Lönnroth T et al. Activity of the 7Be isotope in plants from south-west Finland.
55 Maksimow A et al. Assessing the depth of dexmedetomidine-induced sedation with electroencephalogram (EEG)-based spectral entropy.
56 Martikainen IK et al. Correlation of human cold pressor pain responses with 5-HT 1A receptor binding in the brain.
57 Maunu J et al. Antenatal Doppler measurements and early brain injury in very low birth weight infants.
58 Merisaari H et al. Evaluation of partial volume effect correction methods for brain positron emission tomography: Quantification and reproducibility.
59 Moulin CJA et al. Brain function during multi-trial learning in mild cognitive impairment: A PET activation study.
60 Mäenpää M et al. The effects of surgical levels of sevoflurane and propofol anaesthesia on heart rate variability.
61 Naum A. Advanced Analysis Techniques of Cardiac Positron Emission Tomography.
62 Naum A et al. Simultaneous evaluation of myocardial blood flow, cardiac function and lung water using [15O]H2O and positron emission tomography.
63 Nieminen T et al. Coronary reactivity, homocysteine and methylenetrahydrofolate reductase gene variation in young men during pravastatin therapy.
64 Nuutila J et al. Simultaneous quantitative analysis of FcgammaRI (CD64) expression on neutrophils and monocytes: A new, improved way to detect infections .
65 Nuutila P et al. Positron Emission Tomography in Metabolic Research.
66 Nyman MJ et al. Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with (18F)SPA-RQ.
67 Någren K, Halldin C. 11C-based PET-radiopharmaceuticals of clinical value.
68 Olkkola KT et al. Yleisanestesia-aineet.
69 Paavilainen T et al. Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis.
70 Rantamäki M et al. Do carriers of POLG mutation W748S have disease manifestations?
71 Rautava L et al. Acoustic quality of cry in very-low-birth-weight infants at the age of 1 ½ years.
72 Rinne J et al. Alzheimerin taudin lääkkeet.
73 Salmi E. The Effects of General Anesthetics on GABAergic Neurotransmission - Positron Emission Tomography Studies in Healthy Subjects.
74 Salokangas RKR, Hietala J. Insuliini - ensimmäinen skitsofreniaa ehkäisevä lääke?
75 Salokangas RKR et al. Body mass index and functioning in long-term schizophrenia: results of the DSP project.
76 Saraste A et al. Coronary artery flow velocity profile measured by transthoracic doppler echocardiography predicts myocardial viability after acute myocardial infarction.
77 Scheinin H, Scheinin H. Anestesian mysteeri.
78 Scheinin NM et al. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.
79 Silvanto M et al. Effect of 3 g of intravenous paracetamol on post-operative analgesia, platelet function and liver enzymes in patients undergoing tonsillectomy under local anaesthesia.
80 Suhonen J et al. Parkinsonin taudin muistioireita voidaan tutkija ja hoitaa.
81 Svirskis T et al. Quality of life and functioning ability in subjects vulnerable to psychosis.
82 Syvälahti E, Hietala J. Masennuslääkkeet ja mielialaa tasaavat lääkkeet.
83 Syvälahti E, Hietala J. Anksiolyyttiset lääkeaineet.
84 Särkelä M et al., inventor. Monitoring of the cerebral state of a subject.
85 Teräs M et al. Performance of the new generation of the new whole-body PET/CT scanners: discovery STE and discovery VCT.
86 Tuunanen H et al. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alfa-tropomyosin gene: a positron emission tomography study.
87 Tuunanen H. Myocardial Metabolism and Efficiency in Patients With Hypertrophic and Idiopathic Dilated Cardiomyopathy. With Special Reference to the Effects of Fatty Acid Depletion and Betaoxidation Inhibition.
88 Wallius E. Increasing Statistical Power in Brain PET Studies by Image Analysis Methods: Applications for Drug Development.
89 Wallius E et al. Voxel-based NK 1 receptor occupancy measurements with (18F)SPA-RQ and positron emission tomogrphy: A procedure for assessing errors from image reconstruction and physiological modeling.

Julkaisutietokanta 22.10.2008 Publications Data Base 22.10.2008